Antibiotice plans production for critical medicines
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Local pharma producer Antibiotice is planning a significant investment in the research, development, and production of critical medicines, with a proposed RON 376.8 million.
Ceres Pharma, a Belgian pharmaceutical group, has announced the official completion of the integration process between its Romanian subsidiaries, Dacia Plant and Viva Pharma.
Novartis has over 550 employees in Romania and operates a manufacturing unit in the country.
Turnover was approximately RON 231 million in the first nine months of the year.
Opening of STADA production and supply-chain hub in Turda, Romania, strengthens European security of supply with more than 150 million packs of medicines per year.

Romanian M&A activity recorded 67 transactions in Q1 2026, representing a 29% increase compared to the same period last year when 52 deals were announced, according to a report by EY Romania.
BearingPoint, a management and technology consultancy, has relocated its Bucharest office to Timpuri Noi Square, the office development of Vastint Romania.
Romania's Ministry of Finance has announced the April 2026 edition of Fidelis government bonds, offering tax-free interest rates of up to 7.6% for RON-denominated issues.
PPC Renewables Romania will build a battery energy storage system (BESS) with a capacity of 60 MW / 120 MWh at the Târgușor wind farm in Constanța County.
CITR, the judicial administrator of Șantierul Naval din Mangalia, announced that the creditors' assembly has rejected the proposed reorganisation plan for the company.